News from us and our partners

Tags

Topics

0 results

News
28 June, 2022
Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer
News
22 June, 2022
Avantium and Carlsberg sign offtake agreement on PEF
News
16 June, 2022
GlycoEra AG announces appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer
News
8 June, 2022
Cédric Moreau discusses Apollo deal on "Journal des Biotechs"
News
7 June, 2022
Moon Surgical raises $31.3 million to accelerate development of Maestro Robotic System
News
6 June, 2022
Prometheus Materials raises $8 million to decarbonize the building materials industry, in Series A funding round led by Sofinnova Partners
News
2 June, 2022
EnginZyme and Tetra Pak join forces to advance sustainable food & beverage production
News
1 June, 2022
CinCor doses first patient in Phase 2 trial of baxdrostat
News
25 May, 2022
Henrijette Richter discusses Apollo deal with Børsen: "You have to play in that arena"
News
17 May, 2022
Graziano Seghezzi tells Unquote that after Apollo deal, "We will continue to build on our strategy"
News
16 May, 2022
Papiernik tells Bloomberg that biotech is essential to pharma industry
News
16 May, 2022
Corriere della Serra interviews Graziano Seghezzi after Sofinnova Partners signs deal with Apollo
News
16 May, 2022
Antoine Papiernik tells Le Figaro that Apollo deal will help Sofinnova finance the next generation of game-changing health care start-ups
News
16 May, 2022
Sofinnova Partners and Apollo form strategic partnership in life sciences
News
12 May, 2022
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
News
10 May, 2022
NodThera announces clinical progress for lead NLRP3 inflammasome inhibitors and candidate selection of novel brain-penetrant compound

Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer￼

Avantium and Carlsberg sign offtake agreement on PEF

GlycoEra AG announces appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer

Cédric Moreau discusses Apollo deal on "Journal des Biotechs"

Moon Surgical raises $31.3 million to accelerate development of Maestro Robotic System

Prometheus Materials raises $8 million to decarbonize the building materials industry, in Series A funding round led by Sofinnova Partners

EnginZyme and Tetra Pak join forces to advance sustainable food & beverage production

CinCor doses first patient in Phase 2 trial of baxdrostat

Henrijette Richter discusses Apollo deal with Børsen: "You have to play in that arena"

Graziano Seghezzi tells Unquote that after Apollo deal, "We will continue to build on our strategy"

Papiernik tells Bloomberg that biotech is essential to pharma industry

Corriere della Serra interviews Graziano Seghezzi after Sofinnova Partners signs deal with Apollo

Antoine Papiernik tells Le Figaro that Apollo deal will help Sofinnova finance the next generation of game-changing health care start-ups

Sofinnova Partners and Apollo form strategic partnership in life sciences

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform

NodThera announces clinical progress for lead NLRP3 inflammasome inhibitors and candidate selection of novel brain-penetrant compound

Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer